Aster Dm Healthcare Ltd. · NSE:ASTERDM
Aster Dm Healthcare — Q2 FY21 Earnings Presentation
40 slides from Aster Dm Healthcare's earnings presentation, Nov 10, 2020
Slide 1: Cover letter to stock exchanges
November 10, 2020 The Secretary The Manager, Listing Department, Listing Department, BSE Limited, The National Stock Exchange of India Ltd 1st Floor, Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street, Mumbai 400001 Bandra Kurla Complex Scrip Code: 540975 Bandra (East), Mumbai 40005
Slide 2: Investor Presentation – For the quarter ended 30th September 2020
Investor Presentation – For the quarter ended 30th September 2020 1
Slide 3: Disclaimer
Disclaimer This presentation has been prepared by Aster DM Healthcare Limited (the "Company"), content of which was compiled from sources believed to be reliable for informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other condit
Slide 4: Aster – Overview
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 3
Slide 5: Aster DM Healthcare – Business Overview
Aster DM Healthcare – Business Overview HOSPITALS One of Largest Private INSTALLED CAPACITY BEDS healthcare service providers GCC: 1,163 GCC: 13 4,871 26 India: 3,708 India: 13 operating in Asia (GCC& India) PATIENT VISITS – FY21 H1 Present in 7 Countries CLINICS (UAE, Saudi Arabia, Qatar, Oman, ~6.
Slide 6: Aster DM Healthcare – Financial Overview
Aster DM Healthcare – Financial Overview Note: 1. Revenue and EBITDA shown above excludes other income; 5 2. Above shown percentage of revenue and EBITDA by hospitals, clinics and pharmacies are calculated based on gross segmental numbers before allocation of inter-segment revenue and unallocated co
Slide 7: Geographical Footprint
Geographical Footprint Hospitals – 13 GCC Clinics – 106 Pharmacies – 224 Hospitals – 13 Clinics – 9 INDIA United Arab Emirates Kerala Medcare Hospital, Dubai Aster Medcity, Kochi Medcare Orthopaedics and Spine Hospital Aster MIMS, Calicut Aster Hospital Mankhool Aster MIMS, Kottakkal Medcare Women &
Slide 8: Hospitals List
Hospitals List Commencement/ Bed Operational Owned Hospitals - GCC Location Acquisition Year Capacity Beds /Leased Capacity Operational Geography Medcare Hospital Dubai, UAE 2007 64 55 Leased Beds Beds Al Raffah Hospital Muscat, Oman 2009 86 72 Leased Al Raffah Hospital Sohar, Oman 2010 78 67 Leased
Slide 9: Pipeline Projects
Pipeline Projects Owned / Hospitals - GCC Location Type Planned Beds Expected Completion Year Present Status Leased/O&M Aster Hospital Sharjah, UAE Greenfield 80 Q4 FY 2021 Construction Leased Aster Hospital Muscat, Oman Greenfield (Relocation) 145 Q4 FY 2022 Construction Leased Sanad Hospital Riyad
Slide 10: The Aster DM Healthcare Edge
The Aster DM Healthcare Edge Aster DM – A Healthcare Ecosystem • Presence across hospitals, clinics & pharmacies and providing primary, secondary and tertiary/ quaternary care • Strategic and sizeable network of clinics enable patient feeder structure Differentiated Asset-light Business Model in GCC
Slide 11: Aster DM Healthcare - Evolution
Aster DM Healthcare - Evolution Building the foundations New geographies, segments Brand “Aster” was formed, private equity Robust Growth across all segments and and service offerings investment, further expansion geographies; Rapid Expansion in India 2015: First clinic in Bahrain and in the Philipp
Slide 12: Robust Growth Over Last 5 Years
ROBUST GROWTH OVER LAST 5 YEARS ..Coupled with capacity creation for further growth, which resulted in an extensive geographical footprint # of Units FY15 FY16 FY17 FY18 FY19 FY20 FY21 H1 Hospitals 14 13 18 19 24 25 26 Clinics 69 87 96 101 114 117 115 Pharmacies 166 180 202 207 219 238 224 Total 249
Slide 13: Aster – Overview
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 12
Slide 14: Aster - An Integrated Healthcare Provider
Aster - An Integrated Healthcare Provider FY20 Operational Information 950+ 1,95,000+ Cardiovascular IP Discharges Surgeries ~5.8 mn 14,900+ 900+ Clinic OPD Visits General Bariatric Clinics Surgeries Surgeries $ 1 ₹ 6 0% 2,300+ Joint 1,400+ ~ 9.8 mn Replacements Spine Surgeries Pharmacy Visits 14,00
Slide 15: Aster – A Healthcare Ecosystem
Aster – A Healthcare Ecosystem Aster, over 30 years, has created a healthcare eco-system across two geographical regions In GCC region, Aster’s primary care clinics act as the initial touch-points in the patient journey, while pharmacies and hospitals continue the care For complex tertiary car
Slide 16: GCC Healthcare – Unique Traits
GCC Healthcare – Unique Traits Healthcare market in GCC states have developed certain unique traits due to the higher expat and working age population Prevalence of Primary and Secondary Healthcare Facilities (Private Sector) Due to lower % of older population requirement of tertiary and quaternar
Slide 17: Aster - Awards & Service Excellence
Aster - Awards & Service Excellence JCI Accreditation Padma Shri Award AHPI Awards Medcare Hospital Dubai, Medcare Dr. Azad Moopen, Chairman & Managing Medcity, CMI, MIMS Calicut, WIMS, Orthopedics and Spine Hospitals, Medcare Director – Aster DM Healthcare received Aadhar, Medcare , Medcare Ortho,
Slide 18: Key Highlights – FY21 Q2 (India clinical)
Key Highlights – FY21 Q2 Clinical Highlights - India A complex and risky procedure - Frozen Elephant Trunk Technique, using a frozen elephant trunk (FET) stent-graft was performed on an overseas patient airlifted to Medcity in critical condition by the CTVS team at Aster Medcity. This procedure is
Slide 19: Key Highlights – FY21 Q2 (GCC clinical)
Key Highlights – FY21 Q2 Clinical Highlights - GCC Medcare Hospital, Sharjah successfully treated a premature baby who was born at 26 weeks Doctors at Medcare Orthopedics & Spine Hospital (MOSH) corrected a 13-year-old girl’s spine curvature from 81° to 38° in 12-hour long surgery Aster Hospit
Slide 20: Aster – Overview
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 19
Slide 21: Revenue and Profitability Snapshot – FY21 Q2
Revenue and Profitability Snapshot – FY21 Q2 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) Constant currency growth of Revenue and EBITDA is ~4% and ~6% respectively Notes: 1. Above financials are presented in Rs. Crore 2. Percentages mentioned inside the bars are % to revenue
Slide 22: Revenue and Profitability Snapshot – FY21 H1
Revenue and Profitability Snapshot – FY21 H1 Revenue from Operations EBITDA (excl. Other Income) PAT (Post-NCI) Constant currency growth of Revenue and EBITDA is ~-7% and ~-17% respectively Notes: 1. Above financials are presented in Rs. Crore 2. Percentages mentioned inside the bars are % to reve
Slide 23: Geography-wise Financial – Snapshot Quarterly
Geography-wise Financial – Snapshot Quarterly GCC INDIA CONSOLIDATED FY20 Q2 FY21 Q2 FY20 Q2 FY21 Q2 FY20 Q2 FY21 Q2 Revenue (₹) 1,656 Cr 1,853 Cr 431 Cr 415 Cr 2,087 Cr 2,268 Cr EBITDA (₹) 184 Cr 223 Cr 61 Cr 48 Cr 245 Cr 271 Cr PAT (Post NCI) (₹) -2 Cr 47 Cr 5 Cr -14 Cr 3 Cr 33 Cr Notes: 1. Revenu
Slide 24: Geography-wise Financial – Snapshot Half-Yearly
Geography-wise Financial – Snapshot Half-Yearly GCC INDIA CONSOLIDATED FY20 H1 FY21 H1 FY20 H1 FY21 H1 FY20 H1 FY21 H1 Revenue (₹) 3,314 Cr 3,315 Cr 802 Cr 714 Cr 4,115 Cr 4,028 Cr EBITDA (₹) 375 Cr 353 Cr 93 Cr 61 Cr 469 Cr 414 Cr PAT (Post NCI) (₹) 17 Cr 3 Cr -11 Cr -53 Cr 6 Cr -50 Cr Notes: 1. Re
Slide 25: Geography-wise Business – Snapshot Quarterly
Geography-wise Business – Snapshot Quarterly GCC INDIA CONSOLIDATED FY20 Q2 FY21 Q2 FY20 Q2 FY21 Q2 FY20 Q2 FY21 Q2 Total Capacity Beds 1,101 1,163 3,693 3,708 4,794 4,871 Operational Beds 909 943 2,606 2,664 3,515 3,607 ALOS (Days) 1.9 2.0 3.6 4.1 3.0 3.2 Occupancy 54% 56% 67% 58% 63% 58% Outpatien
Slide 26: Geography-wise Business – Snapshot Half Yearly
Geography-wise Business – Snapshot Half Yearly GCC INDIA CONSOLIDATED FY20 H1 FY21 H1 FY20 H1 FY21 H1 FY20 H1 FY21 H1 Total Capacity Beds 1,101 1,163 3,693 3,708 4,794 4,871 Operational Beds 909 943 2,606 2,664 3,515 3,607 ALOS (Days) 1.9 2.2 3.5 3.8 3.0 3.2 Occupancy 52% 57% 63% 51% 60% 53% Outpati
Slide 27: Segmental Performance FY21-Q2
Segmental Performance FY21-Q2 Growth % India - India - Unallocated Unallocated GCC GCC Hospitals, GCC GCC Hospitals, FY21 Q2 GCC Clinics & Total GCC Clinics & Total Hospitals Pharmacies Clinics and Hospitals Pharmacies Clinics and Eliminations Eliminations Labs Labs No. of Business Units (#) 13 106
Slide 28: Segmental Performance FY21-H1
Segmental Performance FY21-H1 Growth % India - India - Unallocated Unallocated GCC GCC Hospitals, GCC GCC Hospitals, FY21 H1 GCC Clinics & Total GCC Clinics & Total Hospitals Pharmacies Clinics and Hospitals Pharmacies Clinics and Eliminations Eliminations Labs Labs No. of Business Units (#) 13 106
Slide 29: Maturity Wise Hospital Performance – GCC FY21 H1
Maturity Wise Hospital Performance – GCC FY21 H1 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 11% 14% ₹21 3 56% 12.9% 0-3 Years ₹ 164 136 ₹ ~130,300 Over 3 86% 57% ₹208 Years 10 89% ₹ ~159,200 ₹ 1,379 807 15.1% 13
Slide 30: Maturity Wise Hospital Performance – India FY21 H1
Maturity Wise Hospital Performance – India FY21 H1 Key Performance indicators Revenue Maturity Hospitals Operational Beds (INR in Crs.) EBITDA ARPOBD Occupancy EBITDA % (INR in Cr.) 15% 14% ₹3 0-3 Years 2 ₹ ~25,100 65% 2.4% ₹ 104 374 Over 3 86% 49% ₹71 Years 10 85% ₹ ~29,900 ₹588 2,290 12.0% 12 ₹ 69
Slide 31: Financial Summary – Profitability Statement (1/2)
Financial Summary – Profitability Statement (1/2) Particulars (INR Cr) FY21 Q1 FY20 Q2 FY21 Q2 Revenue from operations 1,761 2,087 2,268 Material consumption 584 616 687 Doctors cost 369 474 473 Employee cost (excl. doctors) 374 428 413 Other expenses 291 325 424 EBITDA (excl. other income) 143 245
Slide 32: Financial Summary – Profitability Statement (2/2)
Financial Summary – Profitability Statement (2/2) Particulars (INR Cr) FY20H1 FY21H1 Revenue from operations 4,115 4,028 Material consumption 1,243 1,271 Doctors cost 939 842 Employee cost (excl. doctors) 833 787 Other expenses 631 714 EBITDA (excl. other income) 469 414 EBITDA % 11.4% 10.3% Depreci
Slide 33: Financial Summary – Balance Sheet & Ratios
Financial Summary – Balance Sheet & Ratios As at Mar 31, As at Sep 30, Particulars (INR Cr) 2020 2020 LIABILITIES Shareholders Equity 3,272 3,196 Minority Interest 446 439 Gross Debt 2,972 2,786 Lease Liabilities - INDAS116 2,632 2,576 Other current and non-current liabilities 3,115 3,115 Total Liab
Slide 34: Strategy and Leadership
Aster – Overview Aster – An Integrated Healthcare Provider Operational and Financial Overview Strategy and Leadership 33
Slide 35: ADMHL – Strategy & Outlook (1/2)
ADMHL – Strategy & Outlook (1/2) Strengthening of hub and A comprehensive human Scalable systems Strengthening of our medical spoke model in GCC resource strategy utilizing our implementation, tightly tourism network geographical diversity and integrated with catering to future growth operations/mar
Slide 36: ADMHL – Strategy & Outlook (2/2)
ADMHL – Strategy & Outlook (2/2) Profitability growth & brand Building of brand, talent Specialized, asset-light Cost Optimization positioning using product- and capability in KSA – a growth in India mix and technology key market in GCC • Focus on margin expansion through • There is significant dema
Slide 37: India Strategy
India Strategy India is geographically well positioned for Focus on In line with medical tourism focus on large format from the GCC hospitals in Tier 1 derisking states, MENA business – cities – Hospitals region and South- in Tier 1 cities The new National Health Protection Scheme target of 25% East
Slide 38: Aster Leadership Team
Aster Leadership Team Jobilal M. Vavachan Veneeth Purushotaman Dr. Azad Moopen Chief Executive Officer, Aster Chairman and Managing Director Group Chief Information Officer Retail Alisha Moopen Dr. Harish Pillai Fara Siddiqi Deputy Managing Director Chief Executive Officer –Aster India Group Chief H
Slide 39: Aster Board of Directors
Aster Board of Directors strategy andleadership Dr. Azad Moopen C. John George Suresh M. Kumar Chairman and Managing Director Independent Director Independent Director Dr Layla Mohamed Biju Varkkey Alisha Moopen Deputy Managing Director Al-Marzooqi Independent Director Independent Director Daniel Ro
Slide 40: www.asterdmhealthcare.com
www.asterdmhealthcare.com